StockData
Accendra Health Inc logo

Accendra Health Inc (ACH) stock

ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)

Close on Nov 13, 2026Market cap $10.00MP/E –Yield –

Accendra Health cash

Cash and short-term investments held at the end of each period.

Accendra Health's cash was $26.61M at Sep 30, 2026. For fiscal 2025 it was $281.99M, up 922.7% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $281.99M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$281.99M+922.7%
FY2024Dec 31, 2024$27.57M-89.9%
FY2023Dec 31, 2023$272.92M+216.7%
FY2022Dec 31, 2022$86.19M+19.6%
FY2021Dec 31, 2021$72.04M-46.4%
FY2020Dec 31, 2020$134.51M+58.8%
FY2019Dec 31, 2019$84.69M-18.1%
FY2018Dec 31, 2018$103.37M-1.1%
FY2017Dec 31, 2017$104.52M-43.7%
FY2016Dec 31, 2016$185.49M+15.2%
FY2015Dec 31, 2015$161.02M+183.6%
FY2014Dec 31, 2014$56.77M-44.3%
FY2013Dec 31, 2013$101.91M+4.1%
FY2012Dec 31, 2012$97.89M-28.0%
FY2011Dec 31, 2011$135.94M-14.6%
FY2010Dec 31, 2010$159.21M+65.6%
FY2009Dec 31, 2009$96.14M+1119.1%
FY2008Dec 31, 2008$7.89M-24.1%
FY2007Dec 31, 2007$10.40M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$26.61M-19.0%
Q2 FY2026Jun 30, 2026$7.65M-80.0%
Q1 FY2026Mar 31, 2026$336.88M+466.8%
Q4 FY2025Dec 31, 2025$281.99M+922.7%
Q3 FY2025Sep 30, 2025$32.84M-56.3%
Q2 FY2025Jun 30, 2025$38.26M-86.0%
Q1 FY2025Mar 31, 2025$59.44M-78.1%
Q4 FY2024Dec 31, 2024$27.57M-89.9%
Q3 FY2024Sep 30, 2024$75.09M-70.0%
Q2 FY2024Jun 30, 2024$273.47M-11.5%
Q1 FY2024Mar 31, 2024$270.79M+225.5%
Q4 FY2023Dec 31, 2023$272.92M+216.7%
Q3 FY2023Sep 30, 2023$250.16M+168.4%
Q2 FY2023Jun 30, 2023$309.10M+323.3%
Q1 FY2023Mar 31, 2023$83.19M-63.5%
Q4 FY2022Dec 31, 2022$86.19M+19.6%
Q3 FY2022Sep 30, 2022$93.21M+66.2%
Q2 FY2022Jun 30, 2022$73.03M+18.3%
Q1 FY2022Mar 31, 2022$228.02M+222.2%
Q4 FY2021Dec 31, 2021$72.04M-46.4%
Q3 FY2021Sep 30, 2021$56.08M-75.3%
Q2 FY2021Jun 30, 2021$61.75M-68.6%
Q1 FY2021Mar 31, 2021$70.78M-49.8%
Q4 FY2020Dec 31, 2020$134.51M+58.8%
Q3 FY2020Sep 30, 2020$227.48M+101.3%
Q2 FY2020Jun 30, 2020$196.45M+115.1%
Q1 FY2020Mar 31, 2020$140.99M+87.4%
Q4 FY2019Dec 31, 2019$84.69M-18.1%
Q3 FY2019Sep 30, 2019$113.00M-9.5%
Q2 FY2019Jun 30, 2019$91.34M-22.7%
Q1 FY2019Mar 31, 2019$75.24M-14.1%
Q4 FY2018Dec 31, 2018$103.37M-1.1%
Q3 FY2018Sep 30, 2018$124.89M+26.9%
Q2 FY2018Jun 30, 2018$118.19M+107.1%
Q1 FY2018Mar 31, 2018$87.63M-31.1%
Q4 FY2017Dec 31, 2017$104.52M-43.7%
Q3 FY2017Sep 30, 2017$98.42M–
Q2 FY2017Jun 30, 2017$57.07M–
Q1 FY2017Mar 31, 2017$127.17M–
Q4 FY2016Dec 31, 2016$185.49M–

More Accendra Health figures

See a number that looks wrong?